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Abstract 
We describe a case of papillated Bowen disease (PBD), associated with a clear cell 
atypical fibroxanthoma (CCAFXA). The epidermal lesion showed a bowenoid 
papillomatous growth pattern with histologic features suggestive of infection by human 
papilloma virus (HPV). In the dermis a neoplasm made up by spindled or polygonal cells 
with wide clear cytoplasm and moderate nuclear pleomorphism was found. 
Immunohistochemical characteristics of these two lesions were clearly different. The 
atypical cells of the intraepidermal proliferation were positive for AE1-AE3 
anticytokeratin antibody, EMA, p16, p53 and p63. The dermal tumor was positive for 
vimentin, CD10, CD68, CD99, alpha-1-antitrypsin and c-kit. Histological features and 
immunohistochemical profile of the dermal tumor corresponded to a CCAFXA, a very 
uncommon neoplasm of which only 10 cases have been reported. In situ hybridization 
for numerous types of HPVs was negative in both lesions. 
 
Introduction 
Papillated Bowen disease (PBD) is an uncommon and not well recognized variant of 
Bowen disease (BD) characterized by verrucous-papillomatous architecture with severe 
intraepithelial dysplasia and koilocytic cells in the upper layers of the epidermis, similar to 
genito-anal or extragenital dysplastic lesions associated to human papilloma virus (HPV) 
[1]. Clear cell atypical fibroxanthoma (CCAFXA) is a rare variant of atypical 
fibroxanthoma (AFX) composed of polygonal and spindled cells with clear cytoplasm, 
polymorphic nuclei and abundant mitotic figures. Only 10 cases of CCAFXA have been  
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reported in the literature [2–8]. We describe a case in which both entities are found in a 
unique cutaneous lesion on the face of the patient. To our knowledge, the finding of these 
two unusual entities with different histogenesis in a unique cutaneous lesion has not been 
previously described. 
Case Report: Clinical History 
A 86-year-old male patient had undergone a right nephrectomy because of a chromophobe 
carcinoma in 1997. Two tubular colonic adenomas were removed in 1998 and 1999. A basal cell 
carcinoma on the right ear and an intraepithelial squamous cell carcinoma, also on the right ear, were 
resected in 2007. 
In March 2009, the patient was sent to our dermatology department for evaluation of a crusty lesion 
at the right preauricular area which had occurred 2 months before. It measured 1 × 0.7 cm in size, and 
under the suspicion of a squamous cell carcinoma, it was completely resected. 
Material and Methods 
The specimen was fixed in 10% neutral buffered neutral formalin. Representative sections were 
embedded in paraffin, sectioned at 3 to 4 micrometer thickness and stained with standard HE, PAS and 
PAS after diastase digestion. Immunohistochemical staining of paraffin sections was performed in a 
Dako Techmate 500 Autostainer, using a heat-induced epitope retrieval technique and a universal 
secondary antibody kit (EnVision+System, Peroxidase; DAKO, Carpinteria, Calif., USA). The panel of 
antibodies included: CK AE1-AE3 (Dako 1/50), CK Cam 5.2 (Becton Dickinson prediluted), EMA 
(Dako 1/100), vimentin (Dako 1/800), smooth muscle actin (Dako 1/25), melan A (Dako 1/25), 
α-1-antitrypsin (Dako 1/4,000), S100 protein (Dako 1/100), CD10 (Novocastra 1/20), CD34 
(Novocastra 1/20), CD68 (Dako 1/100), CD99 (Dako 1/40), c-kit (Dako 1/25), Mib 1 (Novocastra 1/10), 
p16 (MTM Prediluted), p53 (Novocastra 1/10) and p63 (Dako 1/10). 
In situ hybridization (ISH) for HPV on paraffin cut sections was performed (as provided in Dako 
ISH Cytomation GentPoint Detection System code K0620) using wide spectrum genomic probe 
(Y 1404) for 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, and 52 serotypes and with complementary genomic 
probe (Y 1443) for 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68 serotypes  
Results 
On light microscopy, an exophytic lesion with verrucous acanthosis, papillomatosis 
and variable hyperkeratosis and parakeratosis was found. The epidermis showed a loss of 
polarity and maturation in the whole thickness of the epithelium with atypical 
keratinocytes and numerous mitotic figures. The lesion contained vacuolated 
keratinocytes in the upper epidermis with koilocytic atypia and light hypergranulosis with 
keratohyaline granules (fig. 1a, b). At the periphery, the lesion was surrounded by 
thickened epidermis with acanthosis and hyperkeratosis, but with good maturation and 
without cellular atypia. In the dermis, just below the dysplastic epithelium and the 
reactive thickened epithelium, a solid tumor was found. It was surrounded by an 
epidermal collarette and did not ulcerate the epidermis. Tumor cells were polygonal or 
spindled with clear or microvacuolated cytoplasm, and the stroma of the tumor showed 
abundant and delicate vessels, with isolated and localized lymphoplasmacytic infiltrates 
(fig. 1c, d). Moderate to marked polymorphism of the nuclei was found throughout the 
tumor and around 5 mitotic figures per 10 high-powered fields, including some abnormal 
forms, were seen (fig. 1e). The cytoplasm of these cells was negative for both PAS stain 
and PAS stain after diastase digestion (fig. 1e). Immunohistochemical profile was 
completely different in the two lesions. The intraepidermal dysplastic proliferation  
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showed cytoplasmic staining for EMA, CK AE1-AE3, and nuclear and cytoplasmic 
staining for p16 in most of the epithelium (fig. 2a). Likewise, these cells presented nuclear 
staining for p53 (20%) and p63 (90%). The antibody Mib-1 demonstrated a proliferation 
index of 50%. The staining for p53 and Mib-1 was localized at different layers of the 
epithelium, whereas the expression of p63 was present in all layers of the epithelium 
(fig. 2b). The cells of the dermal tumor showed strong, diffuse cytoplasmic staining for 
vimentin, α-1-antitrypsin and CD68 (fig. 2c), and diffuse membranous staining for CD10 
(fig. 2d) and CD99. Some isolated cells showed cytoplasmic positivity for c-kit, and the 
proliferation index with the Mib-1 antibody was 30%. Immunostaining for Cam5.2, 
smooth muscle actin, S100 protein, melan A and CD34 were negative in both tumoral 
components. 
ISH for HPV was negative in both bowenoid intraepidermal lesion and dermal tumor. 
Discussion 
Our case shows two very unusual lesions: a BD with papillomatous growth pattern and 
cells with koilocytic characteristics in the epidermis and a CCAFXA in the dermis. The 
histologic features of the epidermal lesion corresponded to a papillomatous BD, an 
uncommon subtype of BD. This entity was recently described by Sun et al. [1] in a study 
or 26 cutaneous lesions, mostly localized on areas exposed to sun rays. These lesions were 
both exophytic and endophytic with verrucous acanthosis and papillomatosis. The 
full-thickness of the epidermis was replaced by atypical keratinocytes, with loss of polarity 
and of the normal maturation of the epithelium. All lesions contained vacuolated 
keratinocytes in the upper 1/3 to 1/4 of the epidermis with koilocytic atypia. 
Hypergranulosis was variable. In their study, using ISH method with widely screening 
genomic probes for HPV types, none of the specimens contained HPV DNA of the more 
common oncogenic HPV types. However, the authors suggested that more sensitive 
procedures, as polymerase chain reaction (PCR), should be used before being sure that 
PBD was pathogenetically not related to HPV infection. More recently, Corbalán-Vélez et 
al. [9] described 9 cases of bowenoid wart (BW) localized on the face, neck and temporal 
region. The lesions showed a verrucous growth pattern with intraepidermal bowenoid 
atypia and epithelial cells with koilocytic changes in the upper layers of the epidermis. 
Immunohistochemically, all cases of BW were negative for p16. PCR for DNA of HPV 
was not useful probably due to problems with the samples. These authors raise the 
possibility that BW, versus PBD, was induced by non-oncogenic HPV as those described 
in warts with in situ carcinoma [10, 11] or perhaps due to a synergistic effect of some type 
of HPV with solar radiation [9]. 
In our case, evidence of HPV infection was not demonstrated by ISH. Nevertheless 
immunohistochemically, we found an intense staining for p16. This finding is in 
agreement with the high incidence of p16 in BD [12, 13]. Willman et al. [13] found that 
88% of cases of BD showed consistent expression of high levels of p16 and lacked pRb, but 
these patterns of expression were seen both in HPV-positive and in HPV-negative lesions. 
With the PCR method only 15% of cases were found to contain HPV DNA [13]. p53 or 
p63 proteins had not been previously studied in any of the cases of PBD or BW. We found 
moderate expression of p53 protein and obvious and intense expression of p63 protein. 
Both p53 and p63 were positive in most of BD [14, 15] and this overexpression could play 
a role in the pattern of differentiation and in the oncogenesis of BD and usual carcinomas 
of the skin [14, 15].  
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PBD and BW show overlap of microscopic findings and could be the same entity. Both 
lesions show histologic characteristics suggestive of HPV infection, but no type of HPV 
has been identified so far [1, 9], and p16 was negative in the 9 cases described by 
Corbalán-Vélez et al. [9]. So the pathogenesis of PBD-BW is not clear and the possible 
role of HPV in the genesis of these lesions keeps on being merely a speculation. 
The dermal neoplasm found in our case is extremely uncommon with only 10 cases of 
CCAFXA described until now [2–8]. This tumor involves older patients, predominantly 
males, with a mean age of 80 years (range: 63–90). Seven tumors were localized on the 
head and neck [3–6, 8], and of the remaining 3 tumors, 1 was on the hand and 2 on the 
forearm [2, 5, 7]. The typical clinical presentation of these lesions consists of a rapidly 
growing nodular tumor of the skin similar to keratoacanthoma. Histologic findings are 
similar in all the reported cases with clear polygonal or spindle cells that showed 
moderate to severe nuclear atypia and common mitotic figures, some of them atypical [2–
8]. One case showed extensive clear cell areas, as well as cellular areas composed of 
spindle cells in a fascicular arrangement [3]. The tumor cells did not stain with PAS or 
PAS after diastase digestion [2–8] and the immunohistochemical profile corresponded to 
a neoplasm without both epithelial and melanocytic features, and constant staining for 
vimentin and CD68 [3–8]. Two cases expressed smooth muscle actin and smooth specific 
actin [3] and one case HMB45 focally [7]. In our immunohistochemical study tumoral 
cells were diffusely stained with vimentin, CD10, CD68, CD99, α-1-antitrypsin, and 
isolated cells for c-kit. Recently, CD99, CD10 and c-kit were described as sensitive 
markers of classic AFX [16–18]. However, these antibodies have not been studied in most 
of the published CCAFXA. Our case is the only with diffuse staining for CD10 and CD99, 
whereas in two previous cases studied with these antibodies only CD99 was positive [6, 8]. 
CCAFXA should be differentiated from dermal neoplasms, either primary or metastatic, 
composed of clear cells such as squamous cell carcinoma, melanoma, basal cell 
carcinoma, adnexal carcinoma, renal cell carcinoma, clear cell sarcoma, cutaneous 
leiomyosarcoma, dermal pleomorphic liposarcoma, parachordoma, clear cell 
dermatofibroma, etc. [2–8]. It is very important to diagnose this tumor correctly because, 
opposite to other dermal tumors with clear cells, CCAFXA has usually a low potential for 
metastatic spread [2–8], like conventional AFX [19]. Diagnosis of CCAFXA is based on 
histological features and mainly on the immunohistochemical profile, different to that of 
the other tumors with clear cells mentioned above [3–8]. 
In classic AFX the overlying epidermis rarely displays actinic atypia [19] and few cases 
of AFX combined with BD have been described. On this topic Engelbrecht et al. [20] 
reported a case of intraepithelial squamous neoplasia and atypical fibroxanthoma of the 
cornea and limbus. Histologic and immunohistochemical findings of this case 
corresponded to an intraepithelial BD, associated with an underlying spindle cell AFX. In 
the 10 cases of CCAFXA the epidermis showed attenuation, ulceration or surface erosion, 
but none of them showed actinic keratosis or BD [2–8]. The association of PBD and 
CCAFXA is an exceptional finding. In the review of the literature we have not found any 
case with these characteristics. The histogenesis of these lesions seems not related, but 
both of them could have a common etiopathogenesis secondary to chronic exposition to 
sun rays. 
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Fig. 1. a Verrucous exophytic lesion with hyper- and parakeratosis on the surface. The growth pattern 
is similar to those of the anal-genital condyloma. HE, ×40. b Disorderly maturation and atypical 
keratinocytes associated with keratinocytes with prominent perinuclear halos reminiscent of koilocytes. 
HE, ×200. c, d Tumoral proliferation with solid or fascicular growth pattern placed below the dysplastic 
epithelium (c) and the reactive epidermis (d). In both areas the spindle or polygonal cells show wide, 
clear, vacuolized cytoplasm. HE, ×200. e Clear cells with moderate nuclear pleomorphism and abundant 
mitotic figures, some of them atypical. PAS, ×400. 
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Fig. 2. a Stain for p16 in most of the bowenoid lesion. The dermal tumor is negative. ×100. b Strong 
nuclear staining for p63 protein in the whole thickness of the dysplastic epithelium. The dermal tumor 
is negative. ×100. c Diffuse cytoplasmic staining for CD68 in spindle cells of the dermal neoplasm. The 
bowenoid lesion is negative. ×100. d Staining for CD10 at the cellular membrane in all the cells of the 
dermal tumor, without expression in the epidermal lesion. ×100. 
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